Icentia Receives U.S. Food and Drug Administration (FDA) Clearance for CardioSTAT(R)

QUEBEC CITY, April 6, 2023 -- (Healthcare Sales & Marketing Network) -- Icentia Inc., today announced that it has received FDA 510(k) clearance for CardioSTAT, an ambulatory, continuous ECG monitoring solution that relies on a wire free, single-use record... Devices, Cardiology, FDA Icentia Inc, CardioSTAT, continuous ECG monitoring
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news